Skip to content
10-Q

Quarterly Report

ImmunoCellular Therapeutics, Ltd.

0000822411-18-000009

← back to feed
Filed
Aug 13, 2018 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2018 · Aug 3, 2018 41.93M sh
Operating Cash Flow Q2 2018 · Jun 30, 2018 −$3.78M
Operating Cash Flow Q2 2018 · Jun 30, 2017 −$9.52M
Cash And Equivalents Q2 2018 · Jun 30, 2018 $2.85M
Cash And Equivalents Q2 2018 · Dec 31, 2017 $6.63M
Cash And Equivalents Q2 2018 · Jun 30, 2017 $1.81M
Cash And Equivalents Q2 2018 · Dec 31, 2016 $11.44M
Stockholders Equity Q2 2018 · Jun 30, 2018 $3.43M
Stockholders Equity Q2 2018 · Dec 31, 2017 $4.65M
Current Liabilities Q2 2018 · Jun 30, 2018 $401.94K
Current Liabilities Q2 2018 · Dec 31, 2017 $2.36M
Current Assets Q2 2018 · Jun 30, 2018 $3.83M
Current Assets Q2 2018 · Dec 31, 2017 $7.01M
Total Assets Q2 2018 · Jun 30, 2018 $3.83M
Total Assets Q2 2018 · Dec 31, 2017 $7.01M
Sga Expense Q2 2018 · Jun 30, 2018 $670.2K
Sga Expense Q2 2018 · Jun 30, 2018 $1.4M
Sga Expense Q2 2018 · Jun 30, 2017 $988.27K
Sga Expense Q2 2018 · Jun 30, 2017 $1.78M
Rd Expense Q2 2018 · Jun 30, 2018 $58.98K
Rd Expense Q2 2018 · Jun 30, 2018 $349.6K
Rd Expense Q2 2018 · Jun 30, 2017 $10.35M
Rd Expense Q2 2018 · Jun 30, 2017 $15.04M
Net Income Q2 2018 · Jun 30, 2018 −$306.7K
Net Income Q2 2018 · Jun 30, 2018 −$1.33M
Net Income restated Q2 2018 · Jun 30, 2017 −$4.05M
Net Income restated Q2 2018 · Jun 30, 2017 −$9.98M
Operating Income Q2 2018 · Jun 30, 2018 −$307.09K
Operating Income Q2 2018 · Jun 30, 2018 −$1.33M
Operating Income Q2 2018 · Jun 30, 2017 −$11.34M
Operating Income Q2 2018 · Jun 30, 2017 −$16.82M
Revenue Q2 2018 · Jun 30, 2018 $0
Revenue Q2 2018 · Jun 30, 2018 $0
Revenue Q2 2018 · Jun 30, 2017 $0
Revenue Q2 2018 · Jun 30, 2017 $0